Clinical Trial Update: The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating zoledronic acid for improving bone density and reducing fractures in liver transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fractures
• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Royal Prince Alfred Hospital, Sydney, Australia | Conditions: Osteoporosis, Liver Transplantation | Phase 4 | Status: COMPLETED